trans,trans-3,4,5-Trifluoro-4'-(4'-propylbicyclohexyl-4-yl)biphenyl>98.0%(GC)5g

5-Amino-1,3,4-thiadiazole-2-sulfonamide>98.0%(HPLC)(T)250mg

4-Pyrrolidin-2-ylpyridine, 95.0%, 10g

Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate, 95%, 5g

3-chloro-6-(2-thienyl)pyridazine, 95.0%, 250mg

(S)-2-(3-Fluorophenyl)pyrrolidine, 95.0%, 1g

(R)-Methyl 4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 98%, 100mg

Plan PL 20x/0.40 objective. Working distance 8.8 mm

1-Benzyl-3-methylpiperidin-4-ol, 95.0%, 250mg

Ethyl 2-hydroxy-4-methylpyrimidine-5-carboxylate, 95.0%, 10g

1-Benzyl-4-phenylamino-4-cyano-piperidine, 95.0%, 25g

4-Bromo-1,5-dimethyl-1 H -pyrazole-3-carboxylic acid ethyl ester, 97%, 5g

4-ETHYNYL-1H-PYRAZOLE, 95.0%, 10g